Health & Fitness

According to FutureWise analysis, the integrated cardiology devices market is expected to reach US$45.51 billion by 2033 at a CAGR of 10.43%.  The integrated cardiology devices market is projected to reach $45.51 billion by 2033, with a compound annual growth rate (CAGR) of 10.43%. This significant growth is primarily driven by the increasing global prevalence of cardiovascular diseases, such as coronary artery disease, arrhythmias, and heart failure, which are among the leading causes of mortality worldwide.  The market is also benefiting from rapid technological advancements, including minimally invasive procedures, remote patient monitoring systems, and AI-powered diagnostic tools that enhance treatment precision and improve patient outcomes. Additionally, rising healthcare expenditures and a growing elderly population, which is more susceptible to cardiac conditions, are significantly increasing the demand for integrated cardiology solutions. North America ... Continue reading →

According to FutureWise analysis, the intelligent asthma monitoring devices market in 2025 is US$0.46 billion and is expected to reach US$2.19 billion by 2033 at a CAGR of 21.54%.   The market for intelligent asthma monitoring devices is experiencing rapid growth, driven by the rising global prevalence of asthma, which affects over 300 million people. This growth is also a response to the increasing demand for personalized and proactive disease management solutions. The rapid adoption of smart inhalers, wearable sensors, and connected spirometers harnesses IoT technology and artificial intelligence to track medication adherence, monitor respiratory patterns, and predict asthma exacerbations in real time.  The growing use of smartphones and the integration of asthma monitoring apps with these devices are empowering patients with actionable insights, allowing healthcare providers to deliver remote care more effectively. North America leads the ... Continue reading →

According to FutureWise analysis, the Interleukin-6 (IL-6) Inhibitors market in 2025 is US$42.83 billion, and is expected to reach US$90.15 billion by 2033 at a CAGR of 9.75%.  The market for Interleukin-6 (IL-6) inhibitors is experiencing significant growth, largely due to their expanding use beyond just rheumatoid arthritis. These inhibitors are increasingly being utilized for conditions such as cytokine release syndrome, complications from COVID-19, and various autoimmune and inflammatory diseases. This market expansion is strongly supported by the success of established therapies like tocilizumab and sarilumab, along with a promising pipeline of new IL-6 pathway inhibitors currently in clinical development. The rising prevalence of autoimmune diseases, particularly among aging populations, is also contributing to this growth. Additionally, increasing diagnostic rates and improved access to biologic therapies are driving greater demand for these targeted treatments.  ... Continue reading →

According to FutureWise analysis, the Interventional Neurology Devices Market in 2025 is US$42.83 billion, and is expected to reach US$90.15 billion by 2033 at a CAGR of 9.75%.  The Interventional Neurology Devices Market is experiencing significant growth due to the rising prevalence of neurological disorders, such as ischemic strokes and brain aneurysms. These conditions affect millions of people worldwide, highlighting the urgent need for innovative, minimally invasive endovascular interventions.  Technological advancements are rapidly evolving treatment options, including thrombectomy devices, flow diverters, embolic coils, and neurovascular stents. These innovations offer faster, safer, and more efficient solutions for acute strokes and cerebrovascular disorders. Awareness of the critical importance of timely intervention, particularly within the "golden hour," is increasing, and the expanding network of stroke centers is boosting procedure volumes ... Continue reading →

Regulatory compliance is crucial in toxicology studies. Non-compliance with GLP requirements may result in regulatory rejections, delayed approvals, and substantial financial losses. Good laboratory practices (GLP) are regulatory frameworks governing nonclinical studies, including toxicological assessments necessary for drug development and chemical safety evaluations. The primary role of the GLP Lab environment is to ensure reliability, data integrity, and regulatory acceptance. A robust GLP implementation directly translates into accurate safety and testing data submission to regulatory bodies.    Regulatory framework and GLP requirements for toxicology studies   Before experimenting with drug compounds in human trials, drug developers evaluate compounds in nonclinical testing and toxicity studies to demonstrate the safety and efficacy of the compound and its readiness for human testing. These nonclinical studies come under GLP regulations. GLP regulations were first ... Continue reading →

According to FutureWise analysis, the immunoassay analyzers market in 2025 is US$ 7.56 billion and is expected to reach US$ 11.83 billion by 2033 at a CAGR of 5.76%. The growth is driven by rising demand for rapid and accurate diagnostic testing in hospitals and labs. Advancements in automated immunoassay analyzers are enhancing sensitivity and efficiency. Additionally, the increasing prevalence of chronic and infectious diseases, along with applications in oncology, cardiology, and endocrinology, is boosting market adoption. An immunoassay is a biochemical technique that leverages antibodies or antigens to detect and quantify macromolecules in a solution. In clinical settings such as hospitals and laboratories, immunoassay analyzers play a crucial role in diagnosing infectious diseases, monitoring drug levels, and conducting allergy tests. These analyzers can perform various types of immunoassay tests, including fluorescence polarization, enzyme detection, ion capture detection, and ... Continue reading →

According to FutureWise analysis the market for implantable insulin pump in 2025 is US$ 3.69 billion, and is expected to reach US$ 7.28 billion by 2033 at a CAGR of 8.86%. The growth in implantable insulin pumps is driven by the rising prevalence of diabetes and the demand for advanced delivery solutions that improve glycemic control and convenience. These pumps offer continuous and precise insulin dosing, lowering hypoglycemia risk and enhancing long-term management, aided by innovations in miniaturization, biocompatible materials, and closed-loop systems. An implanted insulin pump is a medical device designed for permanent placement within the human body. This device delivers insulin directly into the peritoneal cavity, a region rich in blood vessels that allows for more effective insulin absorption. For individuals with diabetes, implanted insulin pumps offer enhanced treatment options, categorized mainly into two types: closed-loop insulin pumps and open-loop insulin pumps. The ... Continue reading →

According to FutureWise analysis the Interventional Radiology Market in 2025 is US$ 29.18 billion, and is expected to reach US$ 43.06 billion by 2033 at a CAGR of 4.98%. Growth in the interventional radiology market is driven by the rising use of image-guided, minimally invasive procedures in oncology, cardiology, and vascular interventions. Advances in imaging, robotics, and device precision are improving safety and outcomes, while the shift to outpatient care and lower healthcare costs further supports market expansion. Interventional Radiology is a specialized area of medicine focused on diagnosing and treating a wide range of medical conditions through minimally invasive techniques. Practitioners known as interventional radiologists utilize various imaging modalities, including X-rays, CT scans, MRI scans, and ultrasounds, to navigate tiny instruments such as catheters and wires within the body. This approach allows for both the diagnosis and treatment of various diseases and ... Continue reading →

According to FutureWise analysis the Interventional Radiology Products Market in 2025 is US$ 13.59 billion, and is expected to reach US$ 22.87 billion by 2033 at a CAGR of 6.72%. The growth of interventional radiology is fueled by a preference for minimally invasive procedures that shorten hospital stays, reduce risks, and improve recovery times. Advancements in imaging, catheters, stents, and embolization devices enhance precision and outcomes. Additionally, the rising incidence of cardiovascular diseases, cancer, and peripheral vascular disorders is increasing demand for these products in hospitals and specialty clinics. Interventional radiology focuses on diagnosing and treating diseases through minimally invasive, imaging-guided techniques. This field has expanded significantly due to its versatile applications in addressing various medical conditions and the rapid advancement of technology. Notably, the rising prevalence of chronic diseases, particularly those affecting blood ... Continue reading →

According to FutureWise analysis the market for intranasal drug delivery devices in 2025 is US$ 1.79 billion, and is expected to reach US$ 3.95 billion by 2033 at a CAGR of 10.40%. Strong growth in intranasal drug delivery is fueled by a preference for non-invasive methods that enhance absorption and bioavailability. These devices are increasingly used for treating neurological disorders, managing pain, and in emergency care due to their quick action. Innovations in formulation and design are broadening their therapeutic uses and market growth. Germs and microbes can enter the body through various mucosal membranes, potentially leading to infections. While there are many parenterally administered vaccines on the market that are effective in generating high levels of systemic immunity, they often do not stimulate mucosal immunity. Nasal vaccines have emerged as an essential tool in providing protection against pathogens that invade through the mucosal surfaces. The nasal route of ... Continue reading →